scholarly article | Q13442814 |
review article | Q7318358 |
P50 | author | Jane E. Freedman | Q125127316 |
P2093 | author name string | Lea M Beaulieu | |
Elaine Lin | |||
P2860 | cites work | Association between Toll-like receptors and the extent and severity of coronary artery disease in patients with stable angina | Q79436666 |
Inhibition of Toll-like receptor 4 with eritoran attenuates myocardial ischemia-reperfusion injury | Q79839081 | ||
Toll-like receptors 2-deficient mice are protected against postischemic coronary endothelial dysfunction | Q79856753 | ||
In vivo effects of lipopolysaccharide and TLR4 on platelet production and activity: implications for thrombotic risk | Q80134207 | ||
Bacterial DNA induces myocardial inflammation and reduces cardiomyocyte contractility: role of toll-like receptor 9 | Q80492358 | ||
Synergistic proinflammatory effects of the antiviral cytokine interferon-alpha and Toll-like receptor 4 ligands in the atherosclerotic plaque | Q81444765 | ||
Expression of functional Toll-like receptors 2 and 4 in human aortic valve interstitial cells: potential roles in aortic valve inflammation and stenosis | Q81453900 | ||
Evidence of Toll-like receptor molecules on human platelets | Q81479217 | ||
Association between plasma levels and immunolocalization of cytokines in heart valve lesions: a possible target for treatment? | Q81947126 | ||
Immunology. Targeting the tolls | Q83154044 | ||
The danger model: a renewed sense of self | Q28214633 | ||
Involvement of TLR4/type I IL-1 receptor signaling in the induction of inflammatory mediators and cell death induced by ethanol in cultured astrocytes | Q28280597 | ||
Vascular cells contribute to atherosclerosis by cytokine- and innate-immunity-related inflammatory mechanisms | Q30319434 | ||
Increased endothelial expression of Toll-like receptor 2 at sites of disturbed blood flow exacerbates early atherogenic events | Q33318184 | ||
Platelets express functional Toll-like receptor-4. | Q33366814 | ||
Toll4 (TLR4) expression in cardiac myocytes in normal and failing myocardium | Q33853586 | ||
Critical role of extracellular heat shock cognate protein 70 in the myocardial inflammatory response and cardiac dysfunction after global ischemia-reperfusion. | Q35109063 | ||
Toll-like receptor 2 plays a critical role in the progression of atherosclerosis that is independent of dietary lipids. | Q36459911 | ||
Emerging paradigm: toll-like receptor 4-sentinel for the detection of tissue damage. | Q36626556 | ||
Mechanisms of disease: Toll-like receptors in cardiovascular disease | Q36891895 | ||
Local expression of Toll-like receptor 4 at the site of ruptured plaques in patients with acute myocardial infarction | Q36907993 | ||
Angiotensin II AT1 receptor blockade decreases lipopolysaccharide-induced inflammation in the rat adrenal gland | Q36972703 | ||
Engagement of specific innate immune signaling pathways during Porphyromonas gingivalis induced chronic inflammation and atherosclerosis | Q36992344 | ||
Synthetic tetra-acylated derivatives of lipid A from Porphyromonas gingivalis are antagonists of human TLR4. | Q37476115 | ||
Expression of Toll-like receptors on human platelets | Q37866864 | ||
Risk of myocardial infarction and stroke after acute infection or vaccination | Q39471364 | ||
Toll-like receptor stimulation in cardiomyoctes decreases contractility and initiates an NF-kappaB dependent inflammatory response | Q40217414 | ||
Soluble forms of Toll-like receptor (TLR)2 capable of modulating TLR2 signaling are present in human plasma and breast milk | Q40609296 | ||
Candesartan inhibits Toll-like receptor expression and activity both in vitro and in vivo | Q41969861 | ||
Stimulation of Toll-like receptor 2 in human platelets induces a thromboinflammatory response through activation of phosphoinositide 3-kinase | Q42137745 | ||
Toll-like receptor-4 is expressed by macrophages in murine and human lipid-rich atherosclerotic plaques and upregulated by oxidized LDL. | Q42514406 | ||
Lipopolysaccharide stimulation of human aortic valve interstitial cells activates inflammation and osteogenesis | Q46092054 | ||
Statins inhibit toll-like receptor 4-mediated lipopolysaccharide signaling and cytokine expression | Q46433219 | ||
Prognostic value of activated toll-like receptor-4 in monocytes following acute myocardial infarction | Q46687558 | ||
Enhanced expression of TLR4 in smooth muscle cells in human atherosclerotic coronary arteries | Q46878271 | ||
Reduced myocardial ischemia-reperfusion injury in toll-like receptor 4-deficient mice | Q47200145 | ||
Endothelial lipase is increased by inflammation and promotes LDL uptake in macrophages. | Q53531751 | ||
Toll-like receptor-4 modulates survival by induction of left ventricular remodeling after myocardial infarction in mice. | Q54534373 | ||
Local Overexpression of Toll-Like Receptors at the Vessel Wall Induces Atherosclerotic Lesion Formation | Q58482495 | ||
Mechanisms of the priming effect of low doses of lipopoly-saccharides on leukocyte-dependent platelet aggregation in whole blood | Q58831626 | ||
Atherosclerotic lesion development and Toll like receptor 2 and 4 responsiveness | Q59981259 | ||
Toll-Like Receptor 4 Mediates Maladaptive Left Ventricular Remodeling and Impairs Cardiac Function After Myocardial Infarction | Q59981285 | ||
Fluvastatin reduces increased blood monocyte Toll-like receptor 4 expression in whole blood from patients with chronic heart failure | Q63341226 | ||
Mannose binding lectin and soluble Toll-like receptor 2 in heart failure following acute myocardial infarction | Q79255657 | ||
P433 | issue | 2 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | cardiovascular disease | Q389735 |
toll-like receptor | Q408004 | ||
P304 | page(s) | 117-123 | |
P577 | publication date | 2009-01-01 | |
P1433 | published in | Cardiovascular Therapeutics | Q1871490 |
P1476 | title | Innate immunity and toll-like receptor antagonists: a potential role in the treatment of cardiovascular diseases | |
P478 | volume | 27 |
Q34519899 | A novel approach for emerging and antibiotic resistant infections: Innate defense regulators as an agnostic therapy |
Q42007802 | Cardioprotective effect of carvedilol: inhibition of apoptosis in H9c2 cardiomyocytes via the TLR4/NF-κB pathway following ischemia/reperfusion injury |
Q36293678 | Effects of Toll-like receptor signals in T-cell neoplasms |
Q50352812 | Expression of toll-like receptor genes in leukocytes of patients with sudden sensorineural hearing loss. |
Q42144631 | Genomics in cardiovascular diseases: analysis of the importance of the toll-like receptor signaling pathway |
Q51601980 | HMGB1 facilitates hypoxia-induced vWF upregulation through TLR2-MYD88-SP1 pathway. |
Q28082430 | Ischemia/reperfusion activates myocardial innate immune response: the key role of the toll-like receptor |
Q35037420 | Regulatory effects of TLR2 on megakaryocytic cell function |
Q38016490 | Role of platelets as mediators that link inflammation and thrombosis in atherosclerosis |
Q34183935 | Sparstolonin B attenuates hypoxia-induced apoptosis, necrosis and inflammation in cultured rat left ventricular tissue slices |
Q39649943 | Sulphoraphane inhibited the expressions of intercellular adhesion molecule-1 and vascular cell adhesion molecule-1 through MyD88-dependent toll-like receptor-4 pathway in cultured endothelial cells |
Q39003281 | TLR signalling and association of TLR polymorphism with cardiovascular diseases |
Q35057385 | TLR2-deficiency of cKit+ bone marrow cells is associated with augmented potency to stimulate angiogenic processes |
Q37731951 | Targeting TLR/IL-1R signalling in human diseases. |
Q37765620 | Targeting inflammation as a therapeutic strategy in accelerated atherosclerosis in rheumatoid arthritis |
Q37925018 | Targeting inflammation in cardiovascular diseases. still a neglected field? |
Q42152131 | The Emerging Role of TLR and Innate Immunity in Cardiovascular Disease |
Q47704782 | The Role of Toll-Like Receptors and Vitamin D in Cardiovascular Diseases-A Review. |
Q55181875 | The function and mechanism of HMGB1 in lung cancer and its potential therapeutic implications. |
Q63379428 | Toll-Like Receptor-Dependent Immunomodulatory Activity of Pycnogenol |
Q33678336 | Toll-like receptor 7 deficiency protects apolipoprotein E-deficient mice from diet-induced atherosclerosis |
Q38053492 | Toll-like receptor signaling pathways in cardiovascular diseases: challenges and opportunities |